Predictive factors of hepatotoxicity in immunotherapy with checkpoint inhibitors in patients treated for melanoma and kidney cancer

Mateusz Malik, Zbyszko Chowaniec, Natasza Kempa-Kamińska, Jerzy Błaszczyk, Emilia Filipczyk-Cisarż

Vol 20, No 3 (2024)

Research paper

Use of next-generation sequencing in daily routine practice

Adam Płużański, Andrzej Tysarowski, Maciej Kawecki, Jakub Kucharz, Kinga Winiarczyk, Maciej Krzakowski

Vol 19, No 6 (2023)

Review paper

Sotorasib for non-small cell lung cancer — current options and perspectives

Magdalena Knetki-Wróblewska, Bartosz Wasąg

Vol 20, No 3 (2024)

Review paper

Combination of chemotherapy and endocrine treatment in breast cancer — is it still a taboo?

Piotr J. Wysocki

Vol 20, No 4 (2024)

Review paper

Diagnosis and treatment of patients with breast cancer and mutation in the BRCA1/2 genes

Joanna Kufel-Grabowska, Bartosz Wasąg

Vol 20, No 3 (2024)

Review paper

LAG-3 as a therapeutic target in melanoma

Anna M Terlecka, Piotr Rutkowski, Paweł Sobczuk

Online first

Review paper

The effect of different concentrations of anti-PD-1 and anti-PD-L1 antibodies on the activity of immune system cells in patients with non-small cell lung cancer

Aleksandra Bożyk, Kamila Wojas-Krawczyk, Marcin Nicoś, Paweł Krawczyk

Vol 20, No 2 (2024)

Research paper

Trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer treatment

Patryk S. Michel, Marek Jankowski, Dawid Sigorski, Tomasz Kubiatowski

Online first

Review paper

Malignant peripheral nerve sheath tumor — from genetics to multidisciplinary treatment

Anna M. Czarnecka, Paulina Chmiel, Paweł Sobczuk, Ewa Bartnik, Mateusz Spałek, Anna Szumera-Ciećkiewicz, Marcin Zdzienicki, Sławomir Falkowski, Piotr Rutkowski

Online first

Review paper

Convolutional neural networks in auto-segmentation of nasopharyngeal carcinoma tumor — a systematic review and meta-analysis

Maryam Zamanian, Iraj Abedi

Vol 20, No 1 (2024)

Review paper

Preventing 5-fluorouracil-induced ischemic events in very high-risk cardiac patients with documented ischemic heart disease: a retrospective cohort analysis

Ahmed Basuoni, Rami Abu Omar, Waleed DawaAlbeit, Ahmad Ghoche, Hasan Al-Sayegh, Issa AI Qarshoubi, Mansour Al-Moundhri

Vol 20, No 4 (2024)

Research paper

Cervical cancer in Poland — epidemiology, prevention, and treatment pathways

Michał Seweryn, Agnieszka Leszczyńska, Jerzy Jakubowicz, Tomasz Banaś

Online first

Research paper

Between “opioidophobia” and the opioid crisis: a cross-sectional comparison of opinions on opioid analgesic treatment between palliative care patients with cancer and physicians in Poland

Maria Wysocka, Anna Kieszkowska-Grudny, Jakub Klimkiewicz, Jerzy Jarosz, Martyna Hordowicz, Andrzej Silczuk, Tomasz Pasierski, Anna Klimkiewicz

Vol 20, No 5 (2024)

Research paper

Two-center experience comparing the use of the FLOT4 and CROSS schemes for patients with gastric, esophageal, and gastroesophageal junction adenocarcinoma

Irene Solana López, David Gutiérrez Abad, Maria Victoria de Torres Olombrada, Elia Martínez Moreno, Ignacio Juez Martel, Alicia Hurtado Nuño, Ana Manuela Martín Fernández de Soignie, Carlos de Zea Luque, Nadia Sánchez Baños, Fátima Escalona Martín, Beatriz Losada Vila, Carmen Pantín González, Laura Rodríguez Lajusticia, Diego Malón Giménez, Beatriz Jiménez Munarriz, Roberto Hernández López, Julia Calzas Rodríguez, Juan Antonio Guerra Martínez

Vol 20, No 5 (2024)

Research paper

Diagnostics and treatment of BRCA-associated cancers with olaparib — expert position statement

Artur Kowalik, Anita Chudecka-Głaz, Joanna Kufel-Grabowska, Iwona Skoneczna, Tomasz Kubiatowski

Vol 20, No 4 (2024)

Guidelines / Expert consensus

mRNA vaccines in the treatment of cancer

Natalia Galant, Natalia Krzyżanowska, Paweł Krawczyk

Online first

Review paper

Metachronous breast cancer in a BRCA1 mutation carrier

Karolina Pięta, Izabela Rudy, Maksymilian Kruczała

Vol 19, No 6 (2023)

Case report

Pembrolizumab in combination with chemotherapy in patients with advanced squamous cell lung cancer — clinical trials and real-world data

Magdalena Knetki-Wróblewska, Dariusz M. Kowalski

Vol 20, No 3 (2024)

Review paper

Novel biomarkers in bone sarcomas — diagnosis, treatment selection, and clinical trials

Anna M. Czarnecka, Piotr Błoński, Paulina Chmiel, Piotr Rutkowski

Online first

Review paper

Cardiac metastasis of lung cancer diagnosed by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)

Yassir Benameur, Salah Nabih Oueriagli, Omar Ait Sahel, Abderrahim Doudouh

Vol 20, No 2 (2024)

Case report

The relationship between inflammation markers, positron emission tomography/computed tomography parameters and disease prognosis in advanced non-small-cell lung cancer patients

Esra Pirinççi, Zeynep Oruç, Senar Ebinç, Yunus Güzel, Halil Kömek, Mehmet Küçüköner, Zuhat Urakçı, Muhammet Ali Kaplan, Bekir Taşdemir, Abdurrahman Işıkdoğan

Vol 20, No 4 (2024)

Research paper

Sex cord-stromal tumors of the testis—a rare group of benign and malignant gonadal neoplasms. Literature review

Krzysztof Kowalik, Katarzyna Hetman, Krystian Kasperowicz, Andrzej Modrzejewski

Vol 20, No 5 (2024)

Review paper

Gemcitabine-related fatal cholestatic hepatitis

Oguzhan Yildiz, Melek Karakurt Eryilmaz, Ali Fuat Gürbüz, Muzaffer Ugrakli, Seda Tas Ayçiçek, Murat Araz, Mehmet Artaç

Online first

Case report

Unlocking the potential: the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) as biomarkers informing immunotherapy outcomes in lung cancer patients — single oncology center experience and literature review

Tomasz Jankowski, Natalia Krzyżanowska, Kamila Wojas-Krawczyk, Aleksandra Grzywna, Paweł Krawczyk, Izabela Chmielewska, Michał Szczyrek, Janusz Milanowski

Vol 20, No 4 (2024)

Research paper

Diagnostics and treatment of aggressive angiomyxoma

Aleksandra Maciejczyk, Karol Bartecki, Anna M. Czarnecka, Anna Szumera-Ciećkiewicz, Mateusz Spałek, Michał Wągrodzki, Piotr Rutkowski, Tomasz Świtaj

Online first

Review paper